CN103621869A - 一种大鲵低聚糖肽保健品 - Google Patents
一种大鲵低聚糖肽保健品 Download PDFInfo
- Publication number
- CN103621869A CN103621869A CN201310571255.9A CN201310571255A CN103621869A CN 103621869 A CN103621869 A CN 103621869A CN 201310571255 A CN201310571255 A CN 201310571255A CN 103621869 A CN103621869 A CN 103621869A
- Authority
- CN
- China
- Prior art keywords
- giant salamander
- extract
- salamander oligosaccharide
- oligosaccharide peptide
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000157862 Dicamptodontidae Species 0.000 title claims abstract description 80
- 229920001542 oligosaccharide Polymers 0.000 title claims abstract description 70
- 150000002482 oligosaccharides Chemical class 0.000 title claims abstract description 70
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 70
- 239000000284 extract Substances 0.000 claims abstract description 78
- 150000004676 glycans Chemical class 0.000 claims abstract description 39
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 39
- 239000005017 polysaccharide Substances 0.000 claims abstract description 39
- 230000000694 effects Effects 0.000 claims abstract description 31
- 239000002994 raw material Substances 0.000 claims abstract description 20
- 239000003814 drug Substances 0.000 claims abstract description 15
- 241000190633 Cordyceps Species 0.000 claims abstract description 6
- 241000427250 Moehringia Species 0.000 claims description 46
- 230000036541 health Effects 0.000 claims description 45
- 239000000047 product Substances 0.000 claims description 40
- 241001248610 Ophiocordyceps sinensis Species 0.000 claims description 38
- 238000002360 preparation method Methods 0.000 claims description 37
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 21
- 230000001954 sterilising effect Effects 0.000 claims description 18
- 239000000843 powder Substances 0.000 claims description 16
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 15
- 239000000706 filtrate Substances 0.000 claims description 15
- 239000012141 concentrate Substances 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 13
- 235000012907 honey Nutrition 0.000 claims description 12
- 108090000790 Enzymes Proteins 0.000 claims description 11
- 102000004190 Enzymes Human genes 0.000 claims description 11
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 11
- 241000112528 Ligusticum striatum Species 0.000 claims description 11
- 240000004824 Trimezia steyermarkii Species 0.000 claims description 11
- 239000002775 capsule Substances 0.000 claims description 11
- 239000009136 dragon's blood Substances 0.000 claims description 11
- 229940088598 enzyme Drugs 0.000 claims description 11
- 239000012153 distilled water Substances 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- 238000010298 pulverizing process Methods 0.000 claims description 10
- 239000006228 supernatant Substances 0.000 claims description 10
- 241000283966 Pholidota <mammal> Species 0.000 claims description 9
- 238000004108 freeze drying Methods 0.000 claims description 9
- 210000003097 mucus Anatomy 0.000 claims description 9
- 239000009636 Huang Qi Substances 0.000 claims description 8
- 238000011049 filling Methods 0.000 claims description 7
- 238000009835 boiling Methods 0.000 claims description 6
- 238000007796 conventional method Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 6
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 6
- 238000000926 separation method Methods 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 239000003390 Chinese drug Substances 0.000 claims description 5
- 108090000526 Papain Proteins 0.000 claims description 5
- 108090000284 Pepsin A Proteins 0.000 claims description 5
- 102000057297 Pepsin A Human genes 0.000 claims description 5
- 239000004365 Protease Substances 0.000 claims description 5
- 229920002472 Starch Polymers 0.000 claims description 5
- 239000002250 absorbent Substances 0.000 claims description 5
- 230000002745 absorbent Effects 0.000 claims description 5
- 108010051873 alkaline protease Proteins 0.000 claims description 5
- 229910052799 carbon Inorganic materials 0.000 claims description 5
- 238000004587 chromatography analysis Methods 0.000 claims description 5
- 235000008216 herbs Nutrition 0.000 claims description 5
- 239000002808 molecular sieve Substances 0.000 claims description 5
- 229940055729 papain Drugs 0.000 claims description 5
- 235000019834 papain Nutrition 0.000 claims description 5
- 229940111202 pepsin Drugs 0.000 claims description 5
- 239000008363 phosphate buffer Substances 0.000 claims description 5
- 239000002244 precipitate Substances 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- 239000011347 resin Substances 0.000 claims description 5
- 229920005989 resin Polymers 0.000 claims description 5
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 235000019698 starch Nutrition 0.000 claims description 5
- 239000008107 starch Substances 0.000 claims description 5
- 238000005406 washing Methods 0.000 claims description 5
- 239000003960 organic solvent Substances 0.000 claims description 4
- 238000005238 degreasing Methods 0.000 claims description 3
- 244000061520 Angelica archangelica Species 0.000 claims 2
- 235000013361 beverage Nutrition 0.000 claims 1
- 230000036039 immunity Effects 0.000 abstract description 9
- 230000001737 promoting effect Effects 0.000 abstract description 6
- 238000005516 engineering process Methods 0.000 abstract description 5
- 206010028980 Neoplasm Diseases 0.000 abstract description 4
- 230000004060 metabolic process Effects 0.000 abstract description 3
- 230000032683 aging Effects 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 17
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 241000699666 Mus <mouse, genus> Species 0.000 description 10
- 241000125175 Angelica Species 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 230000002929 anti-fatigue Effects 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 239000002504 physiological saline solution Substances 0.000 description 7
- 230000037396 body weight Effects 0.000 description 6
- 239000013558 reference substance Substances 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 230000003712 anti-aging effect Effects 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 239000000470 constituent Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 241000545442 Radix Species 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 239000006101 laboratory sample Substances 0.000 description 3
- 210000002540 macrophage Anatomy 0.000 description 3
- 230000000242 pagocytic effect Effects 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 230000009182 swimming Effects 0.000 description 3
- 241000269333 Caudata Species 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 210000000662 T-lymphocyte subset Anatomy 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 150000001413 amino acids Chemical group 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000007365 immunoregulation Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- PQMOXTJVIYEOQL-UHFFFAOYSA-N Cumarin Natural products CC(C)=CCC1=C(O)C(C(=O)C(C)CC)=C(O)C2=C1OC(=O)C=C2CCC PQMOXTJVIYEOQL-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-YMDCURPLSA-N D-galactopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-YMDCURPLSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 206010062049 Lymphocytic infiltration Diseases 0.000 description 1
- 241000283967 Manidae Species 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- FSOGIJPGPZWNGO-UHFFFAOYSA-N Meomammein Natural products CCC(C)C(=O)C1=C(O)C(CC=C(C)C)=C(O)C2=C1OC(=O)C=C2CCC FSOGIJPGPZWNGO-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 208000031845 Pernicious anaemia Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000005809 anti-tumor immunity Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000005195 poor health Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
组别 | CD3+% | CD4+% | CD8+% | CD4+/CD8+% |
生理盐水 | 45.52±0.65 | 33.18±4.84 | 29.10±3.02 | 1.14±0.09 |
样品4 | 62.51±4.33#* | 40.78±4.47#* | 24.83±0.34#* | 1.64±0.55#* |
样品5 | 63.82±6.26#* | 42.53±2.64#* | 24.25±0.27#* | 1.75±0.42#* |
样品6 | 64.48±7.72#* | 45.38±5.26#* | 25.10±5.02#* | 1.81±0.56#* |
样品7 | 63.72±3.24#* | 44.49±1.47#* | 24.46±3.62#* | 1.82±0.33#* |
样品8 | 64.84±7.62#* | 44.80±6.12#* | 25.88±4.69#* | 1.73±0.78#* |
样品9(低) | 53.56±3.42 | 37.38±4.47 | 26.51±4.06 | 1.41±0.55 |
样品10(高) | 63.83±5.37 | 45.12±6.14 | 25.22±5.31 | 1.79±0.54 |
对照组 | 54.38±7.44 | 37.15±4.26 | 26.21±5.25 | 1.42±0.62# |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310571255.9A CN103621869B (zh) | 2013-11-15 | 2013-11-15 | 一种大鲵低聚糖肽保健品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310571255.9A CN103621869B (zh) | 2013-11-15 | 2013-11-15 | 一种大鲵低聚糖肽保健品 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103621869A true CN103621869A (zh) | 2014-03-12 |
CN103621869B CN103621869B (zh) | 2015-05-20 |
Family
ID=50203601
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310571255.9A Active CN103621869B (zh) | 2013-11-15 | 2013-11-15 | 一种大鲵低聚糖肽保健品 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103621869B (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104172353A (zh) * | 2014-06-16 | 2014-12-03 | 四川溪源水产养殖有限公司 | 一种大鲵多肽饮品及其制备方法 |
CN104432083A (zh) * | 2015-01-08 | 2015-03-25 | 四川大学 | 一种抗氧化大鲵多肽口服液及其制备方法 |
CN104840489A (zh) * | 2015-05-23 | 2015-08-19 | 汉中领维生物科技发展有限公司 | 大鲵皮肤黏液提取物在制备抗肺癌药物中的应用 |
CN105664140A (zh) * | 2016-01-15 | 2016-06-15 | 上海荣神生物化学有限公司 | 一种糖肽组合物及其制备方法和用途 |
CN105769926A (zh) * | 2016-02-28 | 2016-07-20 | 汉中领维生物科技发展有限公司 | 大鲵皮肤黏液提取物制备抗乳腺癌药物及其应用 |
CN106176826A (zh) * | 2016-08-18 | 2016-12-07 | 湖州新驰医药科技有限公司 | 一种金蝉花多糖制剂及提取工艺 |
CN110432498A (zh) * | 2019-09-03 | 2019-11-12 | 湖北世厚耀榜纪田农业发展有限公司 | 一种大鲵蛋白肽养生胶囊及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1211434A (zh) * | 1997-09-12 | 1999-03-24 | 吴登举 | 一种抗高原反应口服液及其制备方法 |
CN101991038A (zh) * | 2010-11-17 | 2011-03-30 | 张家界(中国)金驰大鲵生物科技有限公司 | 大鲵低聚糖肽保健食品 |
-
2013
- 2013-11-15 CN CN201310571255.9A patent/CN103621869B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1211434A (zh) * | 1997-09-12 | 1999-03-24 | 吴登举 | 一种抗高原反应口服液及其制备方法 |
CN101991038A (zh) * | 2010-11-17 | 2011-03-30 | 张家界(中国)金驰大鲵生物科技有限公司 | 大鲵低聚糖肽保健食品 |
Non-Patent Citations (1)
Title |
---|
李伟等: "大鲵黏液酶解产物的制备及其抗疲劳作用研究", 《食品工业科技》 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104172353A (zh) * | 2014-06-16 | 2014-12-03 | 四川溪源水产养殖有限公司 | 一种大鲵多肽饮品及其制备方法 |
CN104172353B (zh) * | 2014-06-16 | 2017-01-11 | 四川溪源水产养殖有限公司 | 一种大鲵多肽饮品及其制备方法 |
CN104432083A (zh) * | 2015-01-08 | 2015-03-25 | 四川大学 | 一种抗氧化大鲵多肽口服液及其制备方法 |
CN104840489A (zh) * | 2015-05-23 | 2015-08-19 | 汉中领维生物科技发展有限公司 | 大鲵皮肤黏液提取物在制备抗肺癌药物中的应用 |
CN105664140A (zh) * | 2016-01-15 | 2016-06-15 | 上海荣神生物化学有限公司 | 一种糖肽组合物及其制备方法和用途 |
CN105769926A (zh) * | 2016-02-28 | 2016-07-20 | 汉中领维生物科技发展有限公司 | 大鲵皮肤黏液提取物制备抗乳腺癌药物及其应用 |
CN106176826A (zh) * | 2016-08-18 | 2016-12-07 | 湖州新驰医药科技有限公司 | 一种金蝉花多糖制剂及提取工艺 |
CN110432498A (zh) * | 2019-09-03 | 2019-11-12 | 湖北世厚耀榜纪田农业发展有限公司 | 一种大鲵蛋白肽养生胶囊及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103621869B (zh) | 2015-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103621869B (zh) | 一种大鲵低聚糖肽保健品 | |
CN101513437B (zh) | 一种抗疲劳中药组合物及其制备方法 | |
CN101716240A (zh) | 一种用于改善睡眠、补气生血的制剂 | |
CN104138550A (zh) | 一种治疗消化性溃疡药物的制备方法 | |
CN101716318B (zh) | 一种用于辅助化疗方式治疗消化***肿瘤的中药制剂 | |
CN101711848B (zh) | 一种辅助***的中药组合物 | |
CN101518594B (zh) | 一种抗肿瘤及增强免疫力的中药制剂及其制备方法 | |
CN101564464B (zh) | 一种调节肿瘤患者机体免疫力的中药药物 | |
CN103417911B (zh) | 化疗辅助用中药组合物 | |
CN102988639A (zh) | 一种治疗颈椎病的药物及其制备方法 | |
CN102228620B (zh) | 一种补铁补血的中药复方制剂及其制备方法 | |
CN104825817B (zh) | 一种具有抗肿瘤作用的中药制剂 | |
CN113456776A (zh) | 增强免疫力预防老年性痴呆调节血糖血脂血压的组合物 | |
CN1517115A (zh) | 治疗慢性***的中成药——妇炎胶囊 | |
CN107460090B (zh) | 一种鹿龟保健酒及其制备方法 | |
CN104587300A (zh) | 用于治疗急性白血病的中药组合物及其制备方法 | |
CN101461877B (zh) | 用于恢复妇女体力的药物组合物 | |
CN104800317A (zh) | 一种预防和治疗鸡球虫的中药组合物及制备方法 | |
CN104474259A (zh) | 一种含有藏红花的提高免疫力的中药组合物 | |
CN100475248C (zh) | 一种治疗子宫出血的药物及其制备工艺 | |
CN104707126A (zh) | 一种治疗肺炎链球菌感染性肺炎的药物及制备方法 | |
CN109078094A (zh) | 一种用于预防骨质疏松症的医药组合物及其制备方法 | |
CN108324783A (zh) | 白归参灵冬甘治癌药 | |
CN1316989C (zh) | 治疗缺乏营养性疾病的胶囊及其制备工艺 | |
CN103585434B (zh) | 一种治疗贫血的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191203 Address after: No. e-y-108, Chuangye building, science and Technology Park, Guiyang University, No. 103, jianlongdong Road, Shuanglong Airport Economic Zone, Guiyang City, Guizhou Province, 550005 Patentee after: GUIZHOU XIAOHUA TECHNOLOGY Co.,Ltd. Address before: 550005 103 Longdong Road, Guizhou, Guiyang Patentee before: guiyang university |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230705 Address after: No. C-Y-126, Chuangye Building, University Science Park, Guiyang University, No. 103, Jianlongdong Road, Guizhou Shuanglong Airport Economic Zone, Guiyang City, 550000, Guizhou Province Patentee after: Guizhou Leiyun Biotechnology Co.,Ltd. Address before: No. E-Y-108, Chuangye Building, University Science Park, Guiyang University, No. 103, Jianlongdong Road, Guizhou Shuanglong Airport Economic Zone, Guiyang 550005 Patentee before: GUIZHOU XIAOHUA TECHNOLOGY Co.,Ltd. |